BETA-LACTAM RESISTANCE AMONG ESCHERICHIA-COLI AND KLEBSIELLA SPECIES BLOOD CULTURE ISOLATES IN FINNISH HOSPITALS

被引:9
作者
ARSTILA, T [1 ]
AUVINEN, H [1 ]
HUOVINEN, P [1 ]
AHONEN, E [1 ]
BRANDER, M [1 ]
EEROLA, E [1 ]
ESKOLA, J [1 ]
HAKKARAINEN, K [1 ]
HERVA, E [1 ]
HIRVAS, L [1 ]
HIRVONEN, P [1 ]
JAGERROOS, H [1 ]
JARVINEN, H [1 ]
KATILA, ML [1 ]
KLOSSNER, ML [1 ]
KONTIAINEN, S [1 ]
KORPELA, J [1 ]
KOSKELA, M [1 ]
KOSTIALATHOMPSON, A [1 ]
KARKKAINEN, P [1 ]
LARINKARI, U [1 ]
LEHTONEN, OP [1 ]
LIIMATAINEN, O [1 ]
NISSINEN, A [1 ]
OINONEN, S [1 ]
RENKONEN, OV [1 ]
RUUSKA, P [1 ]
SARKKINEN, H [1 ]
VIKBERG, V [1 ]
机构
[1] KANTA HAME CENT HOSP,SF-13530 HAMEENLINNA,FINLAND
关键词
D O I
10.1007/BF01974636
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The aim of this study was to investigate beta-lactam resistance in Escherichia coli and Klebsiella spp. blood culture isolates in Finland. Special attention was given to extended-spectrum beta-lactamases. A total of 566 Escherichia coli and 108 Klebsiella spp. blood culture isolates were collected from hospitals throughout Finland and their susceptibility to beta-lactam antibiotics studied. Twenty percent of Escherichia coli and 69% of Klebsiella spp. strains were resistant to ampicillin. The mechanisms of resistance were studied by hybridization, isoelectric focusing and the clavulanate double-disk potentiation test. Of the ampicillin-resistant Escherichia coli strains, 83% produced TEM-1. Of the ampicillin-resistant Klebsiella spp. strains, 43% produced SHV-1. Only nine Escherichia coli and three Klebsiella spp. isolates were resistant to cefuroxime (MIC > 32 mu g/ml), and none were resistant to third-generation cephalosporins. These data were compared with cefuroxime and third-generation cephalosporin consumption levels in Finnish hospitals. Although the use of cephalosporins is far more extensive in Finland than in other Scandinavian countries, none of the isolates produced extended-spectrum beta-lactamases. In conclusion, resistance to cefuroxime has remained rare in Finland, and cefuroxime is still an alternative to third-generation cephalosporins in the treatment of septicemia.
引用
收藏
页码:468 / 474
页数:7
相关论文
共 22 条
[1]   ANALYSIS OF BETA-LACTAMASE PRODUCTION IN AMPICILLIN-RESISTANT ESCHERICHIA-COLI ISOLATED FROM BLOOD CULTURES 1983-1989 [J].
ARSTILA, T ;
HUOVINEN, S ;
HUOVINEN, P .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1991, 10 (12) :1068-1070
[2]   CHARACTERIZATION OF A NEW TEM-TYPE BETA-LACTAMASE RESISTANT TO CLAVULANATE, SULBACTAM, AND TAZOBACTAM IN A CLINICAL ISOLATE OF ESCHERICHIA-COLI [J].
BLAZQUEZ, J ;
BAQUERO, MR ;
CANTON, R ;
ALOS, I ;
BAQUERO, F .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (10) :2059-2063
[3]  
BRUNBUISSON C, 1987, LANCET, V2, P302
[4]   A TECHNIQUE FOR RADIOLABELING DNA RESTRICTION ENDONUCLEASE FRAGMENTS TO HIGH SPECIFIC ACTIVITY [J].
FEINBERG, AP ;
VOGELSTEIN, B .
ANALYTICAL BIOCHEMISTRY, 1983, 132 (01) :6-13
[5]   SHV-5, A NOVEL SHV-TYPE BETA-LACTAMASE THAT HYDROLYZES BROAD-SPECTRUM CEPHALOSPORINS AND MONOBACTAMS [J].
GUTMANN, L ;
FERRE, B ;
GOLDSTEIN, FW ;
PINTOSCHUSTER, E ;
ACAR, JF ;
COLLATZ, E .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1989, 33 (06) :951-956
[6]   AMINOGLYCOSIDE RESISTANCE AMONG BLOOD CULTURE ISOLATES [J].
HUOVINEN, P ;
GRONROOS, P ;
HERVA, E ;
KATILA, ML ;
KLOSSNER, ML ;
RENKONEN, OV ;
TOIVANEN, P .
JOURNAL OF CLINICAL MICROBIOLOGY, 1984, 20 (01) :65-69
[7]   DETECTION OF PLASMID-MEDIATED BETA-LACTAMASES WITH DNA PROBES [J].
HUOVINEN, S ;
HUOVINEN, P ;
JACOBY, GA .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1988, 32 (02) :175-179
[8]  
HUOVINEN S, 1988, EUROPEAN J CLIN MICR, V10, P651
[9]   MORE EXTENDED-SPECTRUM BETA-LACTAMASES [J].
JACOBY, GA ;
MEDEIROS, AA .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1991, 35 (09) :1697-1704
[10]   THE FREQUENCY OF EXTENDED-SPECTRUM BETA-LACTAMASES IN ISOLATES OF KLEBSIELLA PNEUMONIAE [J].
KATSANIS, G ;
JACOBY, G .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1992, 29 (03) :345-346